Utility of serum anti‐cetuximab immunoglobulin E levels to identify patients at a high risk of severe hypersensitivity reaction to cetuximab
British Journal of Clinical Pharmacology2016Vol. 83(3), pp. 623–631
Citations Over TimeTop 13% of 2016 papers
Benoît Dupont, Delphine Mariotte, Audrey Emmanuelle Dugué, Bénédicte Clarisse, Jean‐Michel Grellard, E. Babin, Bruno Chauffert, Stéphanie Dakpé, Cristian Moldovan, Karine Bouhier‐Leporrier, Jean‐Marie Reimund, Frédéric Di Fiore, Sylvie Zanetta, Audrey Mailliez, Pascal Dô, Annie Peytier, Marie‐Pierre Galais, Carmen Florescu, Roland Schött, Brigitte Le Mauff, Radj Gervais
Abstract
Detection of pretreatment anti-cetuximab IgE is feasible and helpful to identify patients at risk of severe cetuximab-induced HSRs.
Related Papers
- → Interleucinas na encefalopatia hipóxico-isquêmica(2003)14 cited
- Susquehanna Chorale Spring Concert "Roots and Wings"(2017)
- → Genentech taps Affimed’s antibodies(2018)
- Enxerto livre de arteria epigastrica inferior: avaliacao hemodinamica e angiografica pre e pos-operatoria(1988)
- → KOMPLIKASI REGIONAL ANESTESI PADA PEDIATRIK(2023)